TMIC (The Metabolomics Innovation Centre) was formed in 2011 with the vision of becoming one of the world’s premier metabolomics facilities, offering the widest possible range of cutting-edge, comprehensive, quantitative metabolomic research capabilities and services. It operates as a distributed network platform through an administrative support team and 7 “Nodes” or laboratories distributed among the University of Alberta (UofA – 4 Nodes), the University of Victoria (Uvic – 1 Node), McMaster University (1 Node), and McGill University (1 Node).
TMIC’s vision is:To improve life through the power of metabolomics.
TMIC's mission is:To catalyze innovation and translate metabolomics from the laboratory to real-world use by creating novel technologies, providing cutting-edge analytic services, sharing foundational data resources, and equipping the next generation of scientists and users. The ultimate goal is to enable the creation of a strong metabolomics industry in Canada and generate social and economic benefits for Canadians.
Board of Directors
The TMIC Board of Directors provides strategic direction and advice to TMIC.
|Kevin Keough (Chair) (Executive Director, Alberta Prion Research Institute)|
|Rachael Scarth (Associate Vice President Operations, University of Victoria)|
|Gijs Van Rooijen (Chief Scientific Officer, Genome Alberta)|
|Roger Foxfall (CEO, Life Sciences Strategies Inc.)|
|Marvin Fritzler (Professor, Dept. of Medicine, University of Calgary)|
|Tony Brooks (CFO, Genome British Columbia)|
|Walter Dixon (Interim Vice President of Research and Innovation, University of Alberta)|
|Shelley King (CEO, Natural Products Canada)|
|Dawn Bell (CSO, Novartis Canada)|
|Pam Valentine (CEO, Multiple Sclerosis Society of Canada)|
|Liang Li (Professor, Dept. of Chemistry, University of Alberta)|
|Ana Clementin (Operations Manager, TMIC)|